Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combination

OBJECTIVES: We examined patient-reported outcomes (PROs) in The Study of Etanercept And Methotrexate in Patients with Psoriatic Arthritis (PsA); a 48-week, phase 3, randomised controlled trial that compared outcomes with methotrexate (MTX) monotherapy, etanercept monotherapy, and MTX+ etanercept in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:RMD Open
Asıl Yazarlar: Strand, Vibeke, Mease, Philip J, Maksabedian Hernandez, Ervant J, Stolshek, Bradley S, Liu, Lyrica X H, Collier, David H, Kricorian, Gregory, Merola, Joseph F
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2021
Konular:
Psoriatic Arthritis
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7813325/
https://ncbi.nlm.nih.gov/pubmed/33452180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2020-001484
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller